Array-based proteomics: Mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer

Journal of Pathology

Volumn 208, Issue 5, 2006, Pages 595-606

  Gulmann, C ^a,b   Sheehan, K M ^a,b   Kay, E W ^b   Liotta, L A ^c   Petricoin III, E F ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b BEAUMONT HOSPITAL   (Ireland)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

Bioinformatics; Biomarker discovery; Cancer; Protein microarrays; Proteomics

Indexed keywords

PROTEIN ANTIBODY; PROTEOME;

BAYES THEOREM; BIOINFORMATICS; CANCER; CLINICAL PROTOCOL; CLUSTER ANALYSIS; COMPUTER PROGRAM; DIAGNOSTIC PROCEDURE; DNA MICROARRAY; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; HUMAN; IMAGE ANALYSIS; PATIENT CARE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; RNA TRANSLATION; SIGNAL TRANSDUCTION; STANDARDIZATION; TISSUE MICROARRAY;

HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 33645241277     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1958     Document Type: Review

References (63)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
2. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182.
3. Yardin Y, Ullrich A. EGF and ErbB2 receptor overexpression in human tumours. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988;57:443-478.
4. Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. Br Med J 2000;321:531-535.
5. Sattler M, Salgia R. Targeting c-Kit mutations: basic science to novel therapies. Leukoc Res 2004;28(Suppl 1):S11-S20.
6. Blay JY, Le Cesne A, Alberti L, Ray-Coquart I. Targeted cancer therapies. Bull Cancer 2005;92:E13-E18.
7. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-1730.
8. Petricoin EF, Liotta LA. Molecular profiling of human cancer. Nature Rev Genet 2000;1:48-56.
9. Tyers M, Mann M. From genomics to proteomics. Nature 2003;422:193-197.
10. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000;405:837-846.
11. Aebersold R, Goodlett DR. Mass spectrometry in proteomics. Chem Rev 2001;101:269-295.
12. Chaurand P, Sanders ME, Jensen RA, Caprioli RM. Proteomics in diagnostic pathology. Profiling and imaging proteins directly in tissue sections. Am J Pathol 2004;165:1057-1068.
13. Espina V, Geho D, Mehta AI, Petricoin EF 3rd, Liotta LA, Rosenblatt KP. Pathology of the future: molecular profiling for targeted therapy. Cancer Invest 2005;23:36-46.
14. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumour specimens. Nature Med 1998;4:844-847.
15. Gulmann C, Butler D, Kay E, Grace A, Leader M. Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays. Histopathology 2003;42:70-76.
16. Sauter G, Mirlacher M. Tissue microarrays for predictive molecular pathology. J Clin Pathol 2002;55:575-576.
17. Skotheim RI, Abeler VM, Nesland JM, et al. Candidate genes for testicular cancer evaluated by in situ protein expression analyses on tissue microarrays. Neoplasia 2003;5:397-404.
18. Ginestier C, Charafe-Jauffret E, Penault-Llorca F, et al. Comparative multi-methodological measurement of ErbB2 status in breast cancer. J Pathol 2004;202:286-298.
19. Nocito A, Bubendorf L, Maria Tinner E, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-357.
20. Makretsov NA, Huntsman DG, Nielsen TO, et al. Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma. Clin Cancer Res 2004;10:6143-6151.
21. Haab BB. Methods and applications of antibody microarrays in cancer research. Proteomics 2003;3:2116-2122.
22. Nielsen UB, Geierstanger BH. Multiplexed sandwich assays in microarray format. J Immunol Methods 2004;290:107-120.
23. Choi YS, Pack SP, Yoo YJ. Development of a protein microarray using sequence-specific DNA binding domain on DNA chip surface. Biochem Biophys Res Commun 2005;329:1315-1319.
24. Zhu H, Snyder M. Protein chip technology. Curr Opin Chem Biol 2003;7:55-63.
25. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000;289:1760-1763.
26. de Wildt RM, Mundy CR, Gorick BD, Tomlinson IM. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nature Biotechnol 2000;18:989-994.
27. Arenkov P, Kukhtin A, Gemmell A, Voloshchuk S, Chupeeva V, Mirzabekov A. Protein microchips: use for immunoassay and enzymatic reactions. Anal Biochem 2000;278:123-131.
28. Espina V, Mehta AI, Winters ME, et al. Protein microarrays: molecular profiling technologies for clinical specimens. Proteomics 2003;3:2091-2100.
29. Mendoza LG, McQuary P, Mongan A, Gangadharan R, Brignac S, Eggers M. High-throughput microarray-based enzyme-linked immunosorbent assay (ELISA). Biotechniques 1999;27:778-780, 782-786, 788.
30. Schweitzer B, Roberts S, Grimwade B, et al. Multiplexed protein profiling on microarrays by rolling-circle amplification. Nature Biotechnol 2002;20:359-365.
31. Louhimo J, Finne P, Alfthan H, Stenman UH, Haglund C. Combination of HCGbeta, CA 19-9 and CEA with logistic regression improves accuracy in gastrointestinal malignancies. Anticancer Res 2002;22:1759-1764.
32. Hamelinck D, Zhou H, Li L, et al. Optimised normalization for antibody microarrays and application to serum-protein profiling. Mol Cell Proteomics 2005;4:773-784.
33. Miller JC, Zhou H, Kwekel J, et al. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 2003;3:56-63.
34. Zhou H, Bouwman K, Schotanus M, et al. Two-color, rolling-circle amplification on antibody microarrays for sensitive, multiplexed serum-protein measurements. Genome Biol 2004;5:R28.
35. Knezevic V, Leethanakul C, Bichsel VE, et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001;1:1271-1278.
36. Paweletz CP, Charboneau L, Bichsel VE, et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 2001;20:1981-1989.
37. Liotta LA, Espina V, Mehta AI, et al. Protein microarrays: meeting analytical challenges for clinical applications. Cancer Cell 2003;3:317-325.
38. Geho D, Lahar N, Gurnani P, et al. Pegylated, streptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjug Chem 2005;16:559-566.
39. Gulmann C, Espina V, Petricoin E, et al. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clin Cancer Res 2005;11:5847-5855.
40. Sheehan KM, Calvert VS, Kay EW, et al. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol Cell Proteomics 2005;4:346-355.
41. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001;411:375-379.
42. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science 1996;274:998-1001.
43. Quackenbush J. Computational analysis of microarray data. Nature Rev Genet 2001;2:418-427.
44. Ringer M, Peterson C, Khan J. Analyzing array data using supervised methods. Pharmacogenomics 2002;3:403-415.
45. Shannon W, Culverhouse R, Duscan J. Analyzing microarray data using cluster analysis. Pharmacogenomics 2003;4:41-52.
46. Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI. Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res 2004;10:8229-8234.
47. Poon TCW, Yip T, Chan ATC, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003;49:752-760.
48. Belluco C, Mammano E, Petricoin E, et al. Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. Clin Chim Acta 2005;357:180-183.
49. Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signalling network in mammalian cells. Science 2005;307:1621-1625.
50. Tamayo P, Slonim D, Mesirov J, et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to haematopoietic differentiation. Proc Natl Acad Sci U S A 1999;96:2907-2912.
51. Joliffe T. Principle Components Analysis. Springer: Berlin, 1986.
52. Kurella M, Hsiao LL, Yshida T, et al. DNA microarray analysis of complex biologic processes. J Am Soc Nephrol 2001;12:1072-1078.
53. Mori Y, Selaru FM, Sato F, et al. The impact of microsatellite instability on the molecular phenotype of colorectal tumours. Cancer Res 2003;63:4577-4582.
54. Iwafuchi H. Principle component analysis of salivary gland tumours. Mod Pathol 2004;17:803-810.
55. Dudoit S, Fridlyand J, Speed TP. Comparison of discrimination methods for the classification of tumours using gene expression data. J Am Stat Assoc 2002;97:77-87.
56. Sachs K, Perez O, Pe'er D, Lauffenburger DA, Nolan GP. Causal protein-signalling networks derived from multiparameter single-cell data. Science 2005;308:523-529.
57. Lucas P. Bayesian analysis, pattern analysis, and data mining in health care. Curr Opin Crit Care 2004;10:399-403.
58. Liu CL, Prapong W, Natkunam Y, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002;161:1557-1565.
59. Werner M, Chott A, Fabiano A, Battifora H. Effect of formalin tissue fixation and processing on immunohistochemistry. Am J Surg Pathol 2000;24:1016-1019.
60. Orchard S, Kersey P, Hermjakob H, Apweiler R. Meeting Review: The HUPO Proteomics Standards initiative meeting: towards common standards for exchanging proteomic data. Comp Funct Genomics 2003;4:16-19.
61. Hermjakob H, Montecchi-Palazzi L, Bader G, et al. The HUPO PSI's molecular interaction format - a community standard for the representation of protein interaction data. Nature Biotechnol 2004;22:177-183.
62. Jarvinen AK, Hautaniemi S, Edgren H, et al. Are data from different gene expression microarray platforms comparable? Genomics 2004;83:1164-1168.
63. Araujo RP, Petricoin EF, Liotta LA. A mathematical model of combination therapy using the EGFR signaling network. Biosystems 2005;80:57-69.